Delaflox

Delafloxacin Meglumine INN

Antiinfective

 
 
 
 
 


Indication

Acute Bacterial Skin and Skin Structure Infections (ABSSSI), Community-Acquired Bacterial Pneumonia (CABP).


Dosage and Administration

Indications

Dose

Duration (Days)

Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

300 mg of Delaflox for Injection every 12 hours over 60 minutes by intravenous infusion.

5 to 14

Community-Acquired Bacterial Pneumonia (CABP)

5 to 10

 OR, AS DIRECTED BY PHYSICIAN.


Composition

Delaflox 300 mg IV Injection: Each vial contains 433 mg of Delafloxacin Meglumine as lyophilized powder equivalent to Delafloxacin INN 300 mg for reconstitution and further dilution before intravenous infusion. The lyophilized powder is a light yellow to tan cake, which may exhibit cracking and shrinkage and slight variation in texture and color

 
 

Other Antiinfective Products